New MSRA Treatment Could Bring Billions In Revenues

Mar 04 2013 @ 13:12
Trius Therapeutics (TSRX)   Trius is expecting top-line data from its 2nd Phase III trial of Tedizolid (TR-701...

Will 2013 Be The Year For MultiCell Technologies?

Feb 25 2013 @ 14:05
MultiCell Technologies, Inc. (MCET) is a biopharmaceutical company, engaged in the research, development, and...

Cellceutix Cancer Treatment On Track

Feb 22 2013 @ 23:40
Cellceutix (CTIX:OTC) is a clinical stage biotechnology company focused on discovering small molecule drugs for hard...

Cyclacel Pharmaceuticals offers a nice catalyst trade opportunity

Feb 20 2013 @ 08:05
Cyclacel Pharmaceuticals (NASDAQ: CYCC) is expecting safety data and full myelodysplastic syndromes (MDS) data by...

DARA: Catalyst BioTech Break-Out Trade

Feb 15 2013 @ 08:24
DARA Biosciences (NASDAQ: DARA) is expecting to hear soon on the status of its Orphan Drug application submitted to...

Unusual Option Volume For February 13, 2013

Feb 13 2013 @ 14:35
Tracking unusual option volume can be a great way for investors to follow the smart money.  If a particular option...

Why And How To Play AMRN

Feb 06 2013 @ 08:11
One of the most heavily followed stocks in the healthcare industry is Amarin (NASDAQ: AMRN), which recently...

Top 2 Stocks with Unusual Call Activities on Tuesday: VIVUS and Merck

Feb 05 2013 @ 22:00
Tuesday’s market sentiment was driven by extreme greed with Fear & Greed Index at 85, which had increased from...

January's Top ETF Performers include Healthcare & Energy

Feb 01 2013 @ 15:18
Across twenty five of the most widely traded market, sector and industry ETFs, healthcare and energy were among...

Stocks Losing Favor with Analysts: WFC, ARMH, AXP, IBM, KBR

Jan 23 2013 @ 07:39
Wells Fargo & Co. (NYSE:WFC): The banking stock has been downgraded from Overweight to Neutral by Atlantic...
  • Jump to a different page:
  • 1
  • ...
  • 6
  • 7
  • 8

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

Log in to InvestorsHub
Register Now